Establishment of early diagnosis model for preeclampsia and related neurotoxicity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021788

Enrollment

Unknown

Registered

2019-03-09

Start date

2019-03-07

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Preeclampsia:Preeclampsia

Normal group:Nil

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Criteria for evaluation of healthy pregnant women: 1. After 34 weeks of pregnancy; 2. Absence of cardiovascular and neurologic history; 3. Aged 18 to 45 years old; 4. The age of pregnant women and the number of weeks of pregnancy in BMI, were recorded.

Exclusion criteria

Exclusion criteria: 1. Participating in other clinical trials; 2. Having a serious history of cardiovascular and neurologic diseases; 3. A patient with a serious life-threatening disease. The study criteria were terminated: 1. The subject actively requested to exit the trial; 2. Poor compliance.

Design outcomes

Primary

Measure	Time frame
AEA;	—

Countries

China

Contacts

Public ContactZeyong Yang

International Peace Maternity Child Health Hospital

zeyongy2018@aliyun.com+86 21 64070434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026